This study revealed a new regulatory pathway targeting the lipolytic enzyme HSL in glioblastoma, which can help to further reveal the lipolytic network of glioblastoma and provide potential new therapeutic strategies against glioblastoma. The gene discussed is LIPE; the disease is glioblastoma.